We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current MRCK34 market cap is 2.09B. The company's latest EPS is USD 555.6030 and P/E is 0.17.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 14.63B | 15.78B | 16.11B | 16.66B | 15.62B |
| Operating Income | -1.97B | 5.64B | 6.05B | 3.93B | 4.3B |
| Net Income | -1.23B | 4.76B | 5.46B | 3.16B | 3.74B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 47.99B | 48.7B | 59.28B | 60.12B | 64.17B |
| Operating Income | 7.91B | 12.54B | 17.95B | 2.36B | 19.91B |
| Net Income | 7.07B | 13.05B | 14.52B | 365M | 17.12B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 106.68B | 105.85B | 112.63B | 117.53B | 117.11B |
| Total Liabilities | 69.04B | 65.43B | 68.98B | 72.97B | 70.73B |
| Total Equity | 37.64B | 40.42B | 43.65B | 44.56B | 46.37B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 91.59B | 105.69B | 109.16B | 106.68B | 117.11B |
| Total Liabilities | 66.18B | 67.44B | 63.1B | 69.04B | 70.73B |
| Total Equity | 25.4B | 38.26B | 46.06B | 37.64B | 46.37B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 13.01B | 3.09B | 8.73B | 18.02B | 21.47B |
| Investing | -14.08B | -1.38B | -2.45B | -6.29B | -7.73B |
| Financing | -4.81B | -2.81B | -1.6B | -4.02B | -7.03B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 10.25B | 14.11B | 19.1B | 13.01B | 21.47B |
| Investing | -9.44B | -16.56B | -4.96B | -14.08B | -7.73B |
| Financing | -2.83B | 2.59B | -9.12B | -4.81B | -7.03B |
| Market Cap | 2.09B |
| Price to Earnings Ratio | 0.17 |
| Price to Sales Ratio | 0.04 |
| Price to Cash Ratio | 0.22 |
| Price to Book Ratio | 0.06 |
| Dividend Yield | 2.46% |
| Shares Outstanding | 30.81M |
| Average Volume (1 week) | 12.57k |
| Average Volume (1 Month) | 12.17k |
| 52 Week Change | -10.91% |
| 52 Week High | 94.00 |
| 52 Week Low | 58.00 |
| Spread (Intraday) | 2.09 (3%) |
| Company Name | Merck Drn Ed Mb |
| Address |
820 bear tavern road west trenton, new jersey 08628 1021 |
| Website | https://www.merck.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
